S

Seoulin Bioscience Co Ltd
KOSDAQ:038070

Watchlist Manager
Seoulin Bioscience Co Ltd
KOSDAQ:038070
Watchlist
Price: 6 750 KRW
Market Cap: 61.4B KRW

Wall Street
Price Targets

Price Targets Summary
Seoulin Bioscience Co Ltd

There are no price targets for Seoulin Bioscience Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Seoulin Bioscience Co Ltd Competitors:
Price Targets
KURA
Kura Oncology Inc
217% Upside
VITR
Vitrolife AB
38% Upside
PEB
Pacific Edge Ltd
25% Downside
TLX
Telix Pharmaceuticals Ltd
130% Upside
XGN
Exagen Inc
157% Upside
SYNACT
SynAct Pharma AB
11% Upside
CUV
Clinuvel Pharmaceuticals Ltd
105% Upside
CRBU
Caribou Biosciences Inc
568% Upside

Revenue
Forecast

Revenue Estimate
Seoulin Bioscience Co Ltd

For the last 11 years the compound annual growth rate for Seoulin Bioscience Co Ltd's revenue is 5%. The projected CAGR for the next 10 years is -7%.

5%
Past Growth
-7%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Seoulin Bioscience Co Ltd

For the last 11 years the compound annual growth rate for Seoulin Bioscience Co Ltd's operating income is -12%. The projected CAGR for the next 10 years is 12%.

-12%
Past Growth
12%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Seoulin Bioscience Co Ltd

For the last 11 years the compound annual growth rate for Seoulin Bioscience Co Ltd's net income is -3%. The projected CAGR for the next 10 years is 3%.

-3%
Past Growth
3%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Seoulin Bioscience Co Ltd's stock price target?
Not Available

Seoulin Bioscience Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Seoulin Bioscience Co Ltd's Revenue forecast?
Projected CAGR
-7%

For the last 11 years the compound annual growth rate for Seoulin Bioscience Co Ltd's revenue is 5%. The projected CAGR for the next 10 years is -7%.

What is Seoulin Bioscience Co Ltd's Operating Income forecast?
Projected CAGR
12%

For the last 11 years the compound annual growth rate for Seoulin Bioscience Co Ltd's operating income is -12%. The projected CAGR for the next 10 years is 12%.

What is Seoulin Bioscience Co Ltd's Net Income forecast?
Projected CAGR
3%

For the last 11 years the compound annual growth rate for Seoulin Bioscience Co Ltd's net income is -3%. The projected CAGR for the next 10 years is 3%.

Back to Top